• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-term safety and efficacy of 24-hour levodopa-carbidopa intestinal gel in Parkinson's disease.

作者信息

Morales-Briceño Hugo, Mahant Neil, Ha Ainhi D, Chang Florence C F, Kim Samuel D, Griffith Jane, Tsui David, Galea Donna, Fung Victor S C

机构信息

Movement Disorders Unit, Neurology Department, Westmead Hospital, Corner Darcy and Hawkesbury Road, Westmead, NSW, Australia.

Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

出版信息

Mov Disord. 2019 Nov;34(11):1747-1748. doi: 10.1002/mds.27883. Epub 2019 Oct 11.

DOI:10.1002/mds.27883
PMID:31603586
Abstract
摘要

相似文献

1
Long-term safety and efficacy of 24-hour levodopa-carbidopa intestinal gel in Parkinson's disease.24小时左旋多巴-卡比多巴肠凝胶治疗帕金森病的长期安全性和疗效
Mov Disord. 2019 Nov;34(11):1747-1748. doi: 10.1002/mds.27883. Epub 2019 Oct 11.
2
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.左旋多巴-卡比多巴肠凝胶治疗晚期帕金森病的长期安全性和疗效。
Mov Disord. 2018 Jul;33(6):928-936. doi: 10.1002/mds.27338. Epub 2018 Mar 23.
3
[Treatment for advanced Parkinson's disease with intestinal levodopa/carbidopa gel: review of efficacy and safety].[肠道左旋多巴/卡比多巴凝胶治疗晚期帕金森病：疗效与安全性综述]
Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(11):145-51.
4
Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease.左旋多巴-卡比多巴肠凝胶治疗晚期帕金森病。
Curr Med Res Opin. 2011 May;27(5):907-19. doi: 10.1185/03007995.2011.560146. Epub 2011 Feb 25.
5
Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease.左旋多巴-卡比多巴肠凝胶对177例西班牙晚期帕金森病患者的长期疗效
Neurodegener Dis Manag. 2016 Aug;6(4):289-98. doi: 10.2217/nmt-2016-0021. Epub 2016 Jul 21.
6
Suicide in Parkinson's Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel.
Mov Disord. 2015 Sep;30(10):1434-5. doi: 10.1002/mds.26315. Epub 2015 Jul 17.
7
Reply to letter: Suicide in Parkinson's disease patients treated with levodopa-carbidopa Intestinal Gel.致信回复：接受左旋多巴-卡比多巴肠凝胶治疗的帕金森病患者的自杀问题。
Mov Disord. 2015 Sep;30(10):1435-6. doi: 10.1002/mds.26316. Epub 2015 Jul 16.
8
Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.用控释卡比多巴/左旋多巴治疗帕金森病。
Adv Neurol. 1996;69:487-91.
9
Levodopa-carbidopa intestinal gel (LCIG) infusion during pregnancy and delivery: first documented case.左旋多巴-卡比多巴肠凝胶（LCIG）在妊娠和分娩期间的输注：首例文献记载病例。
Parkinsonism Relat Disord. 2014 Nov;20(11):1317-8. doi: 10.1016/j.parkreldis.2014.09.018. Epub 2014 Sep 17.
10
Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.左旋多巴-卡比多巴肠凝胶在帕金森病患者中的应用：系统评价。
CNS Drugs. 2016 May;30(5):381-404. doi: 10.1007/s40263-016-0336-5.

引用本文的文献

1
Levodopa-Entacapone-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease: A Single Center Real-World Experience.左旋多巴-恩他卡朋-卡比多巴肠凝胶治疗晚期帕金森病：单中心真实世界经验
Pharmaceutics. 2024 Mar 25;16(4):453. doi: 10.3390/pharmaceutics16040453.
2
Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance.持续皮下输注左旋多巴/卡比多巴用于治疗帕金森病的运动波动：起始和维持的注意事项
Clin Park Relat Disord. 2024 Feb 10;10:100239. doi: 10.1016/j.prdoa.2024.100239. eCollection 2024.
3
Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson's disease patients.
在一大群晚期帕金森病患者中，从开始就使用 24 小时左旋多巴卡比多巴肠凝胶。
Sci Rep. 2024 Feb 14;14(1):3676. doi: 10.1038/s41598-024-54299-z.
4
Impact of Infusion Therapies on Quality of Life in Advanced Parkinson's Disease.输液疗法对晚期帕金森病患者生活质量的影响
Neuropsychiatr Dis Treat. 2023 Sep 14;19:1959-1972. doi: 10.2147/NDT.S422717. eCollection 2023.
5
Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose.左旋多巴假期后持续24小时左旋多巴-卡比多巴肠凝胶输注，尽管左旋多巴剂量增加，但仍抑制了难治性异动症。
J Mov Disord. 2022 Sep;15(3):290-292. doi: 10.14802/jmd.22021. Epub 2022 Jul 26.
6
Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson's Disease.严重、复杂异动症的管理挑战。来自大量接受左旋多巴-卡比多巴肠凝胶治疗晚期帕金森病患者队列的数据。
Brain Sci. 2021 Jun 22;11(7):826. doi: 10.3390/brainsci11070826.
7
Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review.肠内给予左旋多巴/卡比多巴治疗晚期帕金森病：系统评价。
Mov Disord. 2021 Aug;36(8):1759-1771. doi: 10.1002/mds.28595. Epub 2021 Apr 25.
8
24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical Recommendations.24 小时左旋多巴-卡比多巴肠凝胶：临床经验与实用建议。
CNS Drugs. 2021 Feb;35(2):137-149. doi: 10.1007/s40263-020-00782-w. Epub 2021 Feb 13.
9
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia.左旋多巴/卡比多巴肠凝胶治疗帕金森病的长期疗效：聚焦异动症
Mov Disord Clin Pract. 2020 Sep 18;7(8):930-939. doi: 10.1002/mdc3.13068. eCollection 2020 Nov.